- Home
- TENX vs ALUR Comparison
TENX vs ALUR Comparison
Compare TENX & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- ALUR
- Stock Information
- Founded
- TENX 1967
- ALUR 2009
- Country
- TENX United States
- ALUR United States
- Employees
- TENX N/A
- ALUR N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- ALUR
- Sector
- TENX Health Care
- ALUR
- Exchange
- TENX Nasdaq
- ALUR Nasdaq
- Market Cap
- TENX 21.6M
- ALUR 22.8M
- IPO Year
- TENX N/A
- ALUR N/A
- Fundamental
- Price
- TENX $6.17
- ALUR $2.52
- Analyst Decision
- TENX Strong Buy
- ALUR Strong Buy
- Analyst Count
- TENX 3
- ALUR 3
- Target Price
- TENX $16.00
- ALUR $22.83
- AVG Volume (30 Days)
- TENX 35.4K
- ALUR 89.4K
- Earning Date
- TENX 08-12-2025
- ALUR 08-12-2025
- Dividend Yield
- TENX N/A
- ALUR N/A
- EPS Growth
- TENX N/A
- ALUR N/A
- EPS
- TENX N/A
- ALUR N/A
- Revenue
- TENX N/A
- ALUR $28,304,000.00
- Revenue This Year
- TENX N/A
- ALUR N/A
- Revenue Next Year
- TENX N/A
- ALUR $49.37
- P/E Ratio
- TENX N/A
- ALUR N/A
- Revenue Growth
- TENX N/A
- ALUR N/A
- 52 Week Low
- TENX $2.80
- ALUR $2.15
- 52 Week High
- TENX $7.89
- ALUR $39.91
- Technical
- Relative Strength Index (RSI)
- TENX 51.83
- ALUR 46.27
- Support Level
- TENX $5.62
- ALUR $2.38
- Resistance Level
- TENX $6.35
- ALUR $2.66
- Average True Range (ATR)
- TENX 0.46
- ALUR 0.14
- MACD
- TENX 0.01
- ALUR -0.01
- Stochastic Oscillator
- TENX 41.49
- ALUR 41.67
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.